Sastasundar Ventures Limited (NSE:SASTASUNDR)
284.85
-2.15 (-0.75%)
Feb 19, 2026, 2:06 PM IST
Sastasundar Ventures Revenue
Sastasundar Ventures had revenue of 3.59B INR in the quarter ending December 31, 2025, with 33.36% growth. This brings the company's revenue in the last twelve months to 12.78B, up 7.93% year-over-year. In the fiscal year ending March 31, 2025, Sastasundar Ventures had annual revenue of 11.51B, down -19.60%.
Revenue (ttm)
12.78B
Revenue Growth
+7.93%
P/S Ratio
0.71
Revenue / Employee
7.71M
Employees
1,657
Market Cap
9.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 11.51B | -2.81B | -19.60% |
| Mar 31, 2024 | 14.31B | 3.71B | 34.95% |
| Mar 31, 2023 | 10.61B | 4.22B | 66.06% |
| Mar 31, 2022 | 6.39B | 879.80M | 15.98% |
| Mar 31, 2021 | 5.51B | 1.64B | 42.39% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 568.09B |
| Cipla | 279.67B |
| Apollo Hospitals Enterprise | 242.15B |
| Divi's Laboratories | 103.14B |
| Sigachi Industries | 4.85B |
| GPT Healthcare | 4.48B |
| Tarsons Products | 4.14B |
| Beta Drugs | 3.90B |